Evidence-Based Management of Head and Neck Vascular Anomalies

308 Pages·2018·15.216 MB·English

by  Jonathan A. Perkins, Karthik Balakrishnan

Evidence-Based
Management of
Head and Neck
Vascular Anomalies
Jonathan A. Perkins
Karthik Balakrishnan
Editors
123
Evidence-Based Management of Head
and Neck Vascular Anomalies
Jonathan A. Perkins
Karthik Balakrishnan
Editors
Evidence-Based
Management of Head
and Neck Vascular
Anomalies
Editors
Jonathan A. Perkins Karthik Balakrishnan
Otolaryngology-Head and Neck Surgery Otorhinolaryngology-Head
University of Washington and Neck Surgery
Seattle Children’s Hospital Mayo Clinic
Seattle, WA Rochester, MN
USA USA
ISBN 978-3-319-92305-5 ISBN 978-3-319-92306-2 (eBook)
https://doi.org/10.1007/978-3-319-92306-2
Library of Congress Control Number: 2018952075
© Springer International Publishing AG, part of Springer Nature 2018
This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or
part of the material is concerned, specifically the rights of translation, reprinting, reuse of
illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way,
and transmission or information storage and retrieval, electronic adaptation, computer software,
or by similar or dissimilar methodology now known or hereafter developed.
The use of general descriptive names, registered names, trademarks, service marks, etc. in this
publication does not imply, even in the absence of a specific statement, that such names are
exempt from the relevant protective laws and regulations and therefore free for general use.
The publisher, the authors, and the editors are safe to assume that the advice and information in
this book are believed to be true and accurate at the date of publication. Neither the publisher nor
the authors or the editors give a warranty, express or implied, with respect to the material
contained herein or for any errors or omissions that may have been made. The publisher remains
neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This Springer imprint is published by the registered company Springer Nature Switzerland AG
The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
We dedicate this book to our parents, families, mentors,
practice partners, and colleagues. They have fostered a spirit of
inquiry in us and supported us in our professional and personal
endeavors. We also dedicate this book to all vascular anomaly
patients and their families. We hope the knowledge contained
here will provide a foundation from which their lives will be
improved.
Acknowledgment
We would like to express our gratitude to: Carrie Capri, for her invaluable
work in keeping this project organized and in facilitating communication
between the many people who contributed to this work; Eden Palmer, for her
dedication and expertise in making every table and image as clear and useful
as possible; Sheila Ganti, for her initial edits on many of the chapters; and
Jackie Morton, for her assistance and skill in conducting the initial literature
searches that formed the foundation of this book.
vii
Contents
1 Evidence-Based Medicine: Key Definitions and Concepts .... 1
C. Carrie Liu and Jennifer Shin
Part I General
2 Challenges and Opportunities for Evidence-Based Practice
in Vascular Anomalies ................................. 17
Karthik Balakrishnan and Jonathan A. Perkins
3 Molecular Genetics and Vascular Anomalies ............... 21
Jonathan A. Perkins, James T. Bennett, and William Dobyns
4 Developmental Vascular Biology ......................... 25
Sheila N. Ganti, Mark W. Majesky, and Jonathan A. Perkins
5 Interventional Radiology Services for Vascular Anomalies:
An Update ........................................... 29
Giridhar Shivaram, Kevin Koo, and Eric J. Monroe
Part II Vascular Tumors
6 Vascular Tumors: Infantile Hemangioma .................. 37
Graham Strub, Robert Sidbury, and Nancy Bauman
7 Congenital Hemangiomas .............................. 47
Megha M. Tollefson
8 Pyogenic Granuloma (Lobular Capillary Hemangioma) ..... 53
Kate Khorsand and Deepti Gupta
9 Tufted Angioma and Kaposiform Hemangioendothelioma ... 59
Deepti Gupta, Amy Geddis, and Robert Chun
10 Juvenile Nasopharyngeal Angiofibroma .................. 67
Erin Kirkham, Scott Manning, and Kris S. Moe
11 Temporal Bone Paraganglioma ......................... 73
Matthew L. Carlson, Alex D. Sweeney, Neil S. Patel,
and George B. Wanna
ix
x Contents
12 Cervical Paraganglioma ................................ 87
Alexander P. Marston and Eric Moore
13 Angiosarcoma ........................................ 95
Katherine A. Lees, Christoph M. Prummer,
and Jeffrey R. Janus
Part III Vascular Tumors: Site-Specific Considerations
14 Periocular Vascular Tumors: Infantile Hemangioma ........ 105
Erin Herlihy and Marcelo Hochman
15 Site-Specific Considerations: Vascular Tumors
and Vascular Malformations of the Ear ................... 113
Josephine A. Czechowicz
16 Nasal and Lip Infantile Hemangiomas .................... 121
Milton Waner and Teresa M. O
17 Vascular Tumors of the Airway .......................... 131
Ravindhra G. Elluru
18 Parotid and Deep Vascular Tumors ....................... 139
Craig Miller and Randall A. Bly
Part IV V ascular Malformations
19 Capillary Malformation ................................ 149
Deepti Gupta and Marcelo Hochman
20 Head and Neck Lymphatic Malformation Diagnosis
and Treatment ....................................... 161
Jonathan A. Perkins, Eric J. Monroe, Randall A. Bly, and
Gridhar Shivaram
21 Venous Malformations ................................. 171
Randall A. Bly, Giri Shivaram, and Eric J. Monroe
22 Intracranial Arteriovenous Malformations ................ 179
Jacob Ruzevick, Gabrielle White-Dzuro, Michael Levitt,
Louis Kim, and Manuel Ferreira Jr.
23 Arteriovenous Malformation ............................ 193
Adam B. Johnson and Gresham T. Richter
Part V Vascular Malformations: Site-Specific Considerations
24 Airway Vascular Malformations ......................... 205
Deanna C. Menapace and Karthik Balakrishnan
25 Dermatologic Considerations in Vascular Malformations .... 213
Megha M. Tollefson
Contents xi
26 Facial, facial skeleton and dental considerations
in vascular malformations .............................. 219
Teresa M. O
27 Oral Cavity and Oropharynx ............................ 233
Joseph L. Edmonds and Sheena Pimpalwar
Part VI Vascular Anomaly Syndromes
28 PHACE Syndrome .................................... 245
Deepti Gupta and Kristine Rosbe
29 Hereditary Hemorrhagic Telangiectasia ................... 253
Anthony B. Law and Greg E. Davis
30 Lymphangiomatosis: Generalized Lymphatic Anomaly,
Gorham-Stout Disease, and Kaposiform
Lymphangiomatosis ................................... 265
Tara L. Wenger and Anne Hing
31 Klippel-Trenaunay Syndrome ........................... 273
Megha M. Tollefson
32 Choanal Atresia-Lymphedema .......................... 281
Graham Strub and Sanjay Parikh
33 PIK3CA-Related Overgrowth Spectrum (PROS) ........... 285
Erin Conboy, James T. Bennett, and David Deyle
34 Blue Rubber Bleb Nevus Syndrome ...................... 297
Janice E. Ma and Jennifer L. Hand
35 Sturge-Weber Syndrome ............................... 301
Catherine Amlie-Lefond
Index ................................................... 309
Contributors
Catherine  Amlie-Lefond, MD Center for Integrative Bran Research,
Seattle, WA, USA
Seattle Children’s Research Center, Seattle, WA, USA
Division of Pediatrics, Neurosciences Center, Seattle Children’s Hospital,
Seattle, WA, USA
Karthik Balakrishnan, MD, MPH Department of Otorhinolaryngology,
Mayo Clinic Children’s Center, Rochester, MN, USA
Nancy  Bauman, MD Division of Otolaryngology, Children’s National
Health System, George Washington University, Washington, DC, USA
James  T.  Bennett, MD, PhD Center for Developmental Biology and
Regenerative Medicine, Seattle Children’s Research Institute, Seattle, WA,
USA
Department of Genetic Medicine, Division of Pediatrics, University of
Washington, Seattle, WA, USA
Seattle Children’s Hospital, Seattle, WA, USA
Randall A. Bly, MD Division of Pediatric Otolaryngology, Seattle Children’s
Hospital, Seattle, WA, USA
Department of Otolaryngology-Head and Neck Surgery, University of
Washington, Seattle, WA, USA
Matthew  L.  Carlson, MD Department of Otorhinolaryngology, Mayo
Clinic, Rochester, MN, USA
Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA
C. Carrie Liu, MD, MPH Division of Otolaryngology–Head and Neck
Surgery, Department of Surgery, University of Calgary, Calgary, AB, Canada
Robert Chun, MD Department of Otolaryngology, Children’s Hospital of
Wisconsin, Medical College of Wisconsin, Milwaukee, WI, USA
Erin Conboy, MD Department of Laboratory Medicine and Pathology,
Mayo Clinic, Rochester, MN, USA
Josephine  A.  Czechowicz, MD Division of Pediatric Otolaryngology,
University of California, San Francisco, UCSF Benioff Children’s Hospital,
San Francisco, CA, USA
xiii